Skip to main content
. 2024 Mar 13;67(6):4936–4949. doi: 10.1021/acs.jmedchem.4c00078

Table 2. Examination of C3-substitution on the Pyridopyrimidinone Core.

graphic file with name jm4c00078_0009.jpg

compound R pAKT AlphaLISA IC50 (nM)a Clint human hepatocytes (mL/min/kg)b
T47D SKBR3
7 –H 78 5894 181
8 –Me 3 1465 340
11 –F 0.3 >10,000 862
12 –CN 1 4739 79
13 –CF3 28 >10,000 N.D.
14 –CONH2 >10,000 >10,000 N.D.
a

Measured inhibition of pAKT formation using alphaLISA after 24 h of treatment.

b

Intrinsic clearance obtained from scaling in vitro half-lives from pooled hepatocytes.